The synthesis of 3-aryl-4-nitrocyclohexanones has been achieved from the Morita–Baylis–Hillmanadducts of β-arylnitroethylenes. The strategy involves proline-catalyzed diastereoselective intramolecularMichaeladdition to obtain 3,4-trans-disubstituted cyclohexanones. This method provides a facile access to (±)-epibatidine analogues.
7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic
申请人:UCB S.A. - DTB
公开号:US06060473A1
公开(公告)日:2000-05-09
7-Azabicyclo[2.2.1]-heptane and -heptene derivatives are disclosed that can be administered to a mammal, including a human, to treat disorders associated with a decrease or increase in cholinergic activity.
2-Phenyl-7-azabicycloheptanes and 6-phenyl-8-azabicyclo
申请人:DUPHAR INTERNATIONAL RESEARCH B.V
公开号:EP0664293A1
公开(公告)日:1995-07-26
The invention relates to a group of novel 2-phenyl-7-azabicyclo [2,2,1] heptane and 6-phenyl-8-azabicyclo [3,2,1] octane derivatives having central nervous system, in particular analgesic activity, and to a method for the preparation of these compounds.
The compounds have the general formula (1)
wherein R is hydrogen or alkyl (1-3C), R₁ is alkyl (1-3C), alkoxy (1-3C), halogen, hydroxy or esterified hydroxy, amino or acetylated amino, or methylenedioxy, n has the value 0-3, and p is 1 or 2.
[EN] 7-AZABICYCLO[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS<br/>[FR] DERIVES DE 7-AZABICYCLO[2.2.1]-HEPTANE ET -HEPTENE UTILISES COMME LIGANDS DES RECEPTEURS CHOLINERGIQUES
申请人:UNIVERSITY OF VIRGINIA
公开号:WO1996006093A1
公开(公告)日:1996-02-29
(EN) 7-Azabicyclo[2.2.1]-heptane and -heptene derivatives are disclosed that can be administered to a mammal, including a human, to treat disorders associated with a decrease or increase in cholinergic activity.(FR) Des dérivés de 7-azabicyclo[2.2.1]-heptane et -heptène peuvent être administrés à un mammifère, y compris l'homme, pour traiter les troubles associés à une augmentation ou une diminution de l'activité cholinergique.